References
- Nguyen, N., Judd, L.M., Kalantzis, A., Whittle, B., Giraud, A.S., and van Driel, I.R. (2011). Random mutagenesis of the mouse genome: a strategy for discovering gene function and the molecular basis of disease. Am J Physiol Gastrointest Liver Physiol 300, G1-11. https://doi.org/10.1152/ajpgi.00343.2010
- Peters, L.L., Robledo, R.F., Bult, C.J., Churchill, G.A., Paigen, B.J., and Svenson, K.L. (2007). The mouse as a model for human biology: a resource guide for complex trait analysis. Nature reviews. Genetics 8, 58-69.
- Boyden, L.M., Choi, M., Choate, K.A., Nelson-Williams, C.J., Farhi, A., Toka, H.R., Tikhonova, I.R., Bjornson, R., Mane, S.M., Colussi, G., et al. (2012). Mutations in kelch-like 3 and cullin 3 cause hypertension and electrolyte abnormalities. Nature 482, 98-102. https://doi.org/10.1038/nature10814
- Brawand, D., Soumillon, M., Necsulea, A., Julien, P., Csardi, G., Harrigan, P., Weier, M., Liechti, A., Aximu-Petri, A., Kircher, M., et al. (2011). The evolution of gene expression levels in mammalian organs. Nature 478, 343-348. https://doi.org/10.1038/nature10532
- Strowig, T., Henao-Mejia, J., Elinav, E., and Flavell, R. (2012). Inflammasomes in health and disease. Nature 481, 278-286. https://doi.org/10.1038/nature10759
- Brodski, C., Vogt Weisenhorn, D.M., and Dechant, G. (2002). Therapy of neurodegenerative diseases using neurotrophic factors: cell biological perspective. Expert Rev Neurother 2, 417-426. https://doi.org/10.1586/14737175.2.3.417
- Ahmad-Annuar, A., Tabrizi, S.J., and Fisher, E.M. (2003). Mouse models as a tool for understanding neurodegenerative diseases. Curr Opin Neurol 16, 451-458.
- Chaible, L.M., Corat, M.A., Abdelhay, E., and Dagli, M.L. (2010). Genetically modified animals for use in research and biotechnology. GMR 9, 1469-1482. https://doi.org/10.4238/vol9-3gmr867
- Van Dyke, T., and Jacks, T. (2002). Cancer modeling in the modern era: progress and challenges. Cell 108, 135-144. https://doi.org/10.1016/S0092-8674(02)00621-9
- Roths, J.B., Foxworth, W.B., McArthur, M.J., Montgomery, C.A., and Kier, A.B. (1999). Spontaneous and engineered mutant mice as models for experimental and comparative pathology: history, comparison, and developmental technology. Lab Anim Sci 49, 12-34.
- Price, D.L., Sisodia, S.S., and Borchelt, D.R. (1998). Genetic neurodegenerative diseases: the human illness and transgenic models. Science 282, 1079-1083. https://doi.org/10.1126/science.282.5391.1079
- Matsushita, H., Vesely, M.D., Koboldt, D.C., Rickert, C.G., Uppaluri, R., Magrini, V.J., Arthur, C.D., White, J.M., Chen, Y.S., Shea, L.K., et al. (2012). Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting. Nature 482, 400-404. https://doi.org/10.1038/nature10755
- Capecchi, M.R. (1989). The new mouse genetics: altering the genome by gene targeting. TIG 5, 70-76. https://doi.org/10.1016/0168-9525(89)90029-2
- Stacey, A., Schnieke, A., McWhir, J., Cooper, J., Colman, A., and Melton, D.W. (1994). Use of double-replacement gene targeting to replace the murine alpha-lactalbumin gene with its human counterpart in embryonic stem cells and mice. Mol Cell Biol 14, 1009-1016. https://doi.org/10.1128/MCB.14.2.1009
- Flint, J., and Mott, R. (2008). Applying mouse complex-trait resources to behavioural genetics. Nature 456, 724-727. https://doi.org/10.1038/nature07630
- Doyle, A., McGarry, M.P., Lee, N.A., and Lee, J.J. (2011). The construction of transgenic and gene knockout/knockin mouse models of human disease. Transgenic Res 21, 327-349
- Skarnes, W.C., Rosen, B., West, A.P., Koutsourakis, M., Bushell, W., Iyer, V., Mujica, A.O., Thomas, M., Harrow, J., Cox, T., et al. (2012). A conditional knockout resource for the genome-wide study of mouse gene function. Nature 474, 337-342.
- Yang, H., Wang, J.R., Didion, J.P., Buus, R.J., Bell, T.A., Welsh, C.E., Bonhomme, F., Yu, A.H., Nachman, M.W., Pialek, J., et al. (2011). Subspecific origin and haplotype diversity in the laboratory mouse. Nat Genet 43, 648-655. https://doi.org/10.1038/ng.847
- Finger, J.H., Smith, C.M., Hayamizu, T.F., McCright, I.J., Eppig, J.T., Kadin, J.A., Richardson, J.E., and Ringwald, M. (2011). The mouse Gene Expression Database (GXD): 2011 update. Nucleic Acids Res 39, D835- 841. https://doi.org/10.1093/nar/gkq1132
- Raymond, C.S., and Soriano, P. (2006). Engineering mutations: deconstructing the mouse gene by gene. Dev Dynam 235, 2424-2436. https://doi.org/10.1002/dvdy.20845
- Jones, J.M., Albin, R.L., Feldman, E.L., Simin, K., Schuster, T.G., Dunnick, W.A., Collins, J.T., Chrisp, C.E., Taylor, B.A., and Meisler, M.H. (1993). mnd2: a new mouse model of inherited motor neuron disease. Genomics 16, 669-677. https://doi.org/10.1006/geno.1993.1246
- Weber, J.S., Jang, W., Simin, K., Lu, W., Yu, J., and Meisler, M.H. (1998). High-resolution genetic, physical, and transcript map of the mnd2 region of mouse chromosome 6. Genomics 54, 107-115. https://doi.org/10.1006/geno.1998.5496
- Jones, J.M., Datta, P., Srinivasula, S.M., Ji, W., Gupta, S., Zhang, Z., Davies, E., Hajnoczky, G., Saunders, T.L., Van Keuren, M.L., et al. (2003). Loss of Omi mitochondrial protease activity causes the neuromuscular disorder of mnd2 mutant mice. Nature 425, 721-727. https://doi.org/10.1038/nature02052
- Li, B., Hu, Q., Wang, H., Man, N., Ren, H., Wen, L., Nukina, N., Fei, E., and Wang, G. (2010). Omi/HtrA2 is a positive regulator of autophagy that facilitates the degradation of mutant proteins involved in neurodegenerative diseases. Cell Death Differ 17, 1773-1784. https://doi.org/10.1038/cdd.2010.55
- Faccio, L., Fusco, C., Chen, A., Martinotti, S., Bonventre, J.V., and Zervos, A.S. (2000). Characterization of a novel human serine protease that has extensive homology to bacterial heat shock endoprotease HtrA and is regulated by kidney ischemia. J Biol Chem 275, 2581-2588. https://doi.org/10.1074/jbc.275.4.2581
- Strauss, K.M., Martins, L.M., Plun-Favreau, H., Marx, F.P., Kautzmann, S., Berg, D., Gasser, T., Wszolek, Z., Muller, T., Bornemann, A., et al. (2005). Loss of function mutations in the gene encoding Omi/HtrA2 in Parkinson's disease. Hum Mol Genet 14, 2099-2111. https://doi.org/10.1093/hmg/ddi215
- Plun-Favreau, H., Klupsch, K., Moisoi, N., Gandhi, S., Kjaer, S., Frith, D., Harvey, K., Deas, E., Harvey, R.J., McDonald, N., et al. (2007). The mitochondrial protease HtrA2 is regulated by Parkinson's disease-associated kinase PINK1. Nat Cell Biol 9, 1243-1252. https://doi.org/10.1038/ncb1644
- Ross, O.A., Soto, A.I., Vilarino-Guell, C., Heckman, M.G., Diehl, N.N., Hulihan, M.M., Aasly, J.O., Sando, S., Gibson, J.M., Lynch, T., et al. (2008). Genetic variation of Omi/HtrA2 and Parkinson's disease. Parkinsonism & Related Disorders 14, 539-543. https://doi.org/10.1016/j.parkreldis.2008.08.003
- Park, H.M., Kim, G.Y., Nam, M.K., Seong, G.H., Han, C., Chung, K.C., Kang, S., and Rhim, H. (2009). The serine protease HtrA2/Omi cleaves Parkin and irreversibly inactivates its E3 ubiquitin ligase activity. Biochem Biophys Res Comm 387, 537-542. https://doi.org/10.1016/j.bbrc.2009.07.079
- Gerhardt, E., Graber, S., Szego, E.M., Moisoi, N., Martins, L.M., Outeiro, T.F., and Kermer, P. (2011). Idebenone and resveratrol extend lifespan and improve motor function of HtrA2 knockout mice. PloS One 6, e28855. https://doi.org/10.1371/journal.pone.0028855
- Baker, B.M., and Haynes, C.M. (2011). Mitochondrial protein quality control during biogenesis and aging. Trends Biochem Sci 36, 254-261. https://doi.org/10.1016/j.tibs.2011.01.004
- Suzuki, Y., Imai, Y., Nakayama, H., Takahashi, K., Takio, K., and Takahashi, R. (2001). A serine protease, HtrA2, is released from the mitochondria and interacts with XIAP, inducing cell death. Mol Cell 8, 613-621. https://doi.org/10.1016/S1097-2765(01)00341-0
- Park, D.W., Nam, M.K., and Rhim, H. (2011). The serine protease HtrA2 cleaves UCH-L1 and inhibits its hydrolase activity: implication in the UCH-L1-mediated cell death. Biochem Biophys Res Comm 415, 24-29. https://doi.org/10.1016/j.bbrc.2011.09.148
- Yoshino, J., and Imai, S. (2011). Mitochondrial SIRT3: a new potential therapeutic target for metabolic syndrome. Mol Cell 44, 170-171. https://doi.org/10.1016/j.molcel.2011.10.005
- Clausen, T., Kaiser, M., Huber, R., and Ehrmann, M. (2011). HTRA proteases: regulated proteolysis in protein quality control. Nature reviews. Mol Cell Biol 12, 152-162.
- Zhou, H., Chen, J., Lu, X., Shen, C., Zeng, J., Chen, L., and Pei, Z. (2012). Melatonin protects against rotenone-induced cell injury via inhibition of Omi and Bax-mediated autophagy in Hela cells. J Pineal Res 52, 120-127. https://doi.org/10.1111/j.1600-079X.2011.00926.x
- Wheeler, D.L., Barrett, T., Benson, D.A., Bryant, S.H., Canese, K., Church, D.M., DiCuccio, M., Edgar, R., Federhen, S., Helmberg, W., et al. (2005). Database resources of the National Center for Biotechnology Information. Nucleic Acids Res 33, D39-45.
- Gray, C.W., Ward, R.V., Karran, E., Turconi, S., Rowles, A., Viglienghi, D., Southan, C., Barton, A., Fantom, K.G., West, A., et al. (2000). Characterization of human HtrA2, a novel serine protease involved in the mammalian cellular stress response. FEBS 267, 5699-5710.
- Tian, E.W., Yu, H., Zhang, D.Y., and Nason, J.D. (2011). Development of microsatellite loci for Blastophaga javana (Agaonidae), the pollinating wasp of Ficus hirta (Moraceae). Am J Bot 98, e41-43. https://doi.org/10.3732/ajb.1000432
- Justice, M.J., Siracusa, L.D., and Stewart, A.F. (2011). Technical approaches for mouse models of human disease. Disease Models & Mechanisms 4, 305-310. https://doi.org/10.1242/dmm.000901
- Smith, K.E., Boules, M., Williams, K., Fauq, A.H., and Richelson, E. (2011). The role of NTS2 in the development of tolerance to NT69L in mouse models for hypothermia and thermal analgesia. Behav Brain Res 224, 344-349. https://doi.org/10.1016/j.bbr.2011.06.014
- Peters, H., Nefedov, M., Sarsero, J., Pitt, J., Fowler, K.J., Gazeas, S., Kahler, S.G., and Ioannou, P.A. (2003). A knock-out mouse model for methylmalonic aciduria resulting in neonatal lethality. J Biol Chem 278, 52909- 52913. https://doi.org/10.1074/jbc.M310533200
- Chuang, L.Y., Yang, C.H., Tsui, K.H., Cheng, Y.H., Chang, P.L., Wen, C.H., and Chang, H.W. (2008). Restriction enzyme mining for SNPs in genomes. Anticancer Res 28, 2001-2007.
- Gautheron, V., Auffret, A., Mattson, M.P., Mariani, J., and Vernet-der Garabedian, B. (2009). A new and simple approach for genotyping Alzheimer's disease presenilin-1 mutant knock-in mice. J Neurosci Meth 181, 235-240. https://doi.org/10.1016/j.jneumeth.2009.05.009
- Ludes-Meyers, J.H., Kil, H., Parker-Thornburg, J., Kusewitt, D.F., Bedford, M.T., and Aldaz, C.M. (2009). Generation and characterization of mice carrying a conditional allele of the Wwox tumor suppressor gene. PloS One 4, e7775. https://doi.org/10.1371/journal.pone.0007775
- Haraguchi, S., and Nakagawara, A. (2009). A simple PCR method for rapid genotype analysis of the TH-MYCN transgenic mouse. PloS One 4, e6902. https://doi.org/10.1371/journal.pone.0006902
- Shin, J.H., Hakim, C.H., Zhang, K., and Duan, D. (2011). Genotyping mdx, mdx3cv, and mdx4cv mice by primer competition polymerase chain reaction. Muscle Nerve 43, 283-286. https://doi.org/10.1002/mus.21873
- Lorenzi, H., Duvall, N., Cherry, S.M., Reeves, R.H., and Roper, R.J. (2010). PCR prescreen for genotyping the Ts65Dn mouse model of Down syndrome. Bio Techniques 48, 35-38. https://doi.org/10.2144/000113342
- Luther, R.J., Almodovar, A.J., Fullerton, R., and Wood, P.A. (2012). Acadl- SNP based genotyping assay for long-chain acyl-CoA dehydrogenase deficient mice. Mol Genet Metabol 106, 62-67 https://doi.org/10.1016/j.ymgme.2012.02.009
- Babaei, Z., Oormazdi, H., Rezaie, S., Rezaeian, M., and Razmjou, E. (2011). Giardia intestinalis: DNA extraction approaches to improve PCR results. Exp Parasitol 128, 159-162. https://doi.org/10.1016/j.exppara.2011.02.001
- Gita, S., Suneeta, M., Anjana, S., Niranjan, N., Sujata, M., and Pandey, R.M. (2011). C. trachomatis in female reproductive tract infections and RFLP-based genotyping: a 16-year study from a tertiary care hospital. Infect Dis Obstet Gynecol 2011, 548219.
- Haliassos, A., Chomel, J.C., Tesson, L., Baudis, M., Kruh, J., Kaplan, J.C., and Kitzis, A. (1989). Modification of enzymatically amplified DNA for the detection of point mutations. Nucleic Acids Res 17, 3606. https://doi.org/10.1093/nar/17.9.3606
- Ambrosone, C.B., and Harris, C.C. (2010). The development of molecular epidemiology to elucidate cancer risk and prognosis: a historical perspective. IJMEG 1, 84-91.
Cited by
- HtrA2 suppresses autoimmune arthritis and regulates activation of STAT3 vol.6, pp.1, 2016, https://doi.org/10.1038/srep39393
- Serine Protease HtrA2/Omi Deficiency Impairs Mitochondrial Homeostasis and Promotes Hepatic Fibrogenesis via Activation of Hepatic Stellate Cells vol.8, pp.10, 2012, https://doi.org/10.3390/cells8101119